On today’s STOP TRADING segment on CNBC, Jim Cramer covered a few issues.
He noted Pfizer (PFE) again, saying it was another Bristol-Myers (BMY). He said it is a $25.00 bond now, that has almost no upside. Regarding the safety board, he said them not even knowing of a possibility of issues.
Going hunting, Cramer said Cabellas (CAB) is one that is winning from hunting trends again. He said the analysts also refuse to upgrade it and they might be wrong.
Cramer thinks Archer-Daniels (ADM) is a winner trading cheap.
Jon C. Ogg
December 4, 2006
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
